Insider · CIK 0002019791

English Emily

Reports to the SEC for 1 company · FREDERICK, MD

sec.gov

Transactions

Companies

Filings

CIK

0002019791

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-02	RNACCartesian Therapeutics, Inc.A Award	Chief Operations Officer	AAward	+24K sh	—	—	94,226
2026-01-02	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Operations Officer	AAward	+71K sh	—	—	71,000
2025-12-30	RNACCartesian Therapeutics, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+7,500 sh	$3.30	+$24.8K	70,226
2025-12-30	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	−7,500 sh	—	—	19,369
2025-11-28	RNACCartesian Therapeutics, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+7,500 sh	$3.30	+$24.8K	62,726
2025-11-28	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	−7,500 sh	—	—	26,869
2025-05-12	RNACCartesian Therapeutics, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+7,500 sh	$3.30	+$24.8K	55,226
2025-05-12	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	−7,500 sh	—	—	34,369
2025-04-15	RNACCartesian Therapeutics, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+7,500 sh	$3.30	+$24.8K	47,726
2025-04-15	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	−7,500 sh	—	—	41,869
2025-01-06	RNACCartesian Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−906 sh	$16.83	−$15.2K	40,226
2025-01-03	RNACCartesian Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−891 sh	$16.72	−$14.9K	41,132
2025-01-02	RNACCartesian Therapeutics, Inc.A Award	Chief Operations Officer	AAward	+16.1K sh	—	—	42,023
2025-01-02	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Operations Officer	AAward	+47.4K sh	—	—	47,400
2024-12-26	RNACCartesian Therapeutics, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+7,650 sh	$3.30	+$25.2K	25,923
2024-12-26	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	−7,650 sh	—	—	49,369

Recent filings

Accepted (ET)
Jan 64
English Emily0001453687-26-000031
SEC(opens sec.gov)
Jan 24
English Emily0001453687-26-000002
SEC(opens sec.gov)
Dec 24
English Emily0001453687-25-000130
SEC(opens sec.gov)
May 144
English Emily0001453687-25-000089
SEC(opens sec.gov)
Apr 164
English Emily0001453687-25-000068
SEC(opens sec.gov)
Jan 74
English Emily0001453687-25-000037
SEC(opens sec.gov)
Jan 64
English Emily0001453687-25-000026
SEC(opens sec.gov)
Dec 304
English Emily0001453687-24-000149
SEC(opens sec.gov)

Companies

Cartesian Therapeutics, Inc.Chief Operations OfficerRNAC

Address

C/O CARTESIAN THERAPEUTICS, INC. 7495 NEW HORIZON WAY

FREDERICK, MD, 21703